Ito Y et al (2018) Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients. World J Surg 42(3):615–622
Article PubMed PubMed Central Google Scholar
AIOM, I Numeri del cancro. 2023.
AIOM. I Numeri del cancro. 2019.
Cabanillas ME, McFadden DG, Durante C (2016) Thyroid cancer. Lancet 388(10061):2783–2795
Article CAS PubMed Google Scholar
Sutherland R et al (2021) Papillary thyroid microcarcinoma: Is active surveillance always enough? Clin Endocrinol (Oxf) 95(6):811–817
Lim H et al (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13):1338–1348
Article PubMed PubMed Central Google Scholar
Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2019) SEER Cancer Statistics Review, 1975–2016. National Cancer Institute, Bethesda
Vigneri R, Malandrino P, Russo M (2020) Is thyroid cancer increasing in incidence and aggressiveness? J Clin Endocrinol Metab 105(7):e2639
Vaccarella S et al (2016) Worldwide thyroid-cancer epidemic? the increasing impact of overdiagnosis. N Engl J Med 375(7):614–617
Smallridge RC, Copland JA (2010) Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol (R Coll Radiol) 22(6):486–497
Article CAS PubMed Google Scholar
Dal Maso L et al (2017) Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 77:140–152
Chen DW et al (2023) Thyroid cancer. Lancet 401(10387):1531–1544
Durante C et al (2023) European thyroid association clinical practice guidelines for thyroid nodule management. Eur Thyroid J. https://doi.org/10.1530/ETJ-23-0067
Article PubMed PubMed Central Google Scholar
Amendola S et al (2023) Evaluation of the performance of ACR TI-RADS also considering those nodules with no indication of FNAC: a single-center experience. J Clin Med 12(2):398
Article CAS PubMed PubMed Central Google Scholar
Ruan J et al (2024) Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients. Endocrine 83(2):414–421
Article CAS PubMed Google Scholar
Roh JL, Kim JM, Park CI (2008) Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 15(9):2482–2486
Ito Y et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34(1):28–35
Del Rio P et al (2023) Management of surgical diseases of thyroid gland indications of the United Italian Society of Endocrine Surgery (SIUEC). Updates Surg 75(6):1393–1417
Article PubMed PubMed Central Google Scholar
Ardito G et al (2013) Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy. Clin Nucl Med 38(1):25–28
Yu XM et al (2011) Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254(4):653–660
Liu C et al (2019) Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer 19(1):622
Article PubMed PubMed Central Google Scholar
Wu X et al (2023) Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma. Cancer Med 12(6):7560–7566
Article CAS PubMed Google Scholar
Wei X et al (2022) Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma. J Endocrinol Invest 45(3):507–515
Article CAS PubMed Google Scholar
Al Afif A et al (2015) Multifocal papillary thyroid cancer increases the risk of central lymph node metastasis. Thyroid 25(9):1008–1012
Ozdemir K et al (2023) Should multifocality be an indication for prophylactic central neck dissection in papillary thyroid cancer? Updates Surg 75(3):701–706
Zeng X et al (2021) High incidence of distant metastasis is associated with histopathological subtype of pediatric papillary thyroid cancer—a retrospective analysis based on SEER. Front Endocrinol (Lausanne) 12:760901
Amendola S et al (2024) Papillary thyroid carcinoma: </= 10 mm does not always mean pN0 A multicentric real-world study. Updates Surg 76(3):1055–1061
Article PubMed PubMed Central Google Scholar
Nardi F et al (2014) Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest 37(6):593–599
Leenhardt L et al (2013) 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J 2(3):147–159
Article CAS PubMed PubMed Central Google Scholar
Pizzimenti C et al (2022) Aggressive variants of follicular cell-derived thyroid carcinoma: an overview. Endocrine 78(1):1–12
Article CAS PubMed Google Scholar
Londero SC et al (2015) Papillary thyroid carcinoma in Denmark, 1996–2008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort. Thyroid 25(1):78–84
Gao M et al (2017) 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med 14(3):203–211
Article PubMed PubMed Central Google Scholar
Sugitani I (2023) Active surveillance of low-risk papillary thyroid microcarcinoma. Best Pract Res Clin Endocrinol Metab 37(1):101630
Lee JS et al (2023) Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm. J Clin Endocrinol Metab 108(6):1370–1375
Ito Y et al (2014) Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24(1):27–34
Article CAS PubMed PubMed Central Google Scholar
Machens A, Dralle H (2012) Correlation between the number of lymph node metastasis and lung metastasis in papillary thyroid cancer. J Clin Endocrinol Metab 97(12):4375–4382
Article CAS PubMed Google Scholar
Koo BS et al (2009) Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg 249(5):840–844
Comments (0)